C'mon Mozz, who understands the science better than a well cashed up big or medium sized pharma? Who has had access to the data room & management for well over a year now?
I have laid out in a table what the top 20 pharmas by sales spend on R&D, they would have literally have NOTHING to lose, yet they still sat clear.
I struggle with this sentence below:
"if nothing else a private consortium, a corner stone, some group that understands a the science well and can see and interpret the green light ".
How would involvement from a Venture capitalists or Private equity group look for Paradigm, page-46
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 65468 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |